HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teatulohi Matainaho Selected Research

Phospholipases (Phospholipase)

5/2011Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teatulohi Matainaho Research Topics

Disease

5Neoplasms (Cancer)
02/2016 - 09/2005
2Bites and Stings (Sting)
04/2012 - 05/2011
2Lung Neoplasms (Lung Cancer)
06/2008 - 01/2008
1Osteosarcoma (Osteogenic Sarcoma)
02/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2014
1Huntington Disease (Huntington's Disease)
04/2014
1Mycoses (Diseases, Fungus)
01/2013
1Respiratory Paralysis
04/2012
1Thrombosis (Thrombus)
04/2012
1Myotoxicity
05/2011
1Neuroblastoma
01/2008
1Carcinogenesis
08/2007
1Atherosclerosis
01/2007

Drug/Important Bio-Agent (IBA)

1nahuoic acid AIBA
02/2016
1Histones (Histone)IBA
02/2016
1AcidsIBA
02/2016
1PolyketidesIBA
02/2016
1Histone MethyltransferasesIBA
02/2016
1TransferasesIBA
02/2016
1polyglutamineIBA
04/2014
1Proteins (Proteins, Gene)FDA Link
04/2014
1Antiviral Agents (Antivirals)IBA
01/2013
1VenomsIBA
04/2012
1Prothrombin (Factor II)IBA
04/2012
1Phospholipases (Phospholipase)IBA
05/2011
1Antivenins (Antivenoms)IBA
05/2011
1apratoxin DIBA
06/2008
1Cytotoxins (Cytolysins)IBA
01/2008
1Peptide Hydrolases (Proteases)FDA Link
01/2008
1Serine Proteases (Serine Protease)IBA
01/2008
1TrypsinIBA
01/2008
1symplocamide AIBA
01/2008
1ChymotrypsinFDA Link
01/2008
1Viral ProteinsIBA
08/2007
1AntioxidantsIBA
01/2007
1Peptides (Polypeptides)IBA
09/2005
12,5-dichloro-4-bromophenol (B 2)IBA
09/2005

Therapy/Procedure

1Therapeutics
05/2011